Seladelpar in patients with primary biliary cholangitis and compensated cirrhosis: Efficacy and safety from RESPONSE and ASSURE studies.
Saved in:
| Title: | Seladelpar in patients with primary biliary cholangitis and compensated cirrhosis: Efficacy and safety from RESPONSE and ASSURE studies. |
|---|---|
| Authors: | Gordon SC; Division of Hepatology, Henry Ford Health, Wayne State University School of Medicine, Detroit, Michigan, USA.; College of Medicine, Michigan State University, East Lansing, Michigan, USA., Villamil A; The Liver Autoimmunity Unit, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina., Jacobson IM; NYU Grossman School of Medicine, New York, New York, USA., Lawitz EJ; Texas Liver Institute, University of Texas Health San Antonio, San Antonio, Texas, USA., Younes Z; Gastro One, Germantown, Tennessee, USA., Silveira MG; Department of Medicine, Yale University School of Medicine, New Haven, Connecticut, USA., Bowlus CL; Division of Gastroenterology and Hepatology, University of California, Davis School of Medicine, Sacramento, California, USA., Drenth JPH; Department of Gastroenterology and Hepatology, Amsterdam UMC, Amsterdam, The Netherlands., Vierling JM; Section of Gastroenterology and Hepatology and Division of Abdominal Transplantation, Baylor College of Medicine, Houston, Texas, USA., Morgera U; Internal Medicine, Outpatient Clinic, Charité, Universitätsmedizin Berlin, Berlin, Germany., Vasura A; Department of Internal Medicine and Cardiology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Czech Republic., Dalekos G; Department of Medicine and Research Laboratory of Internal Medicine, National Expertise Center of Greece in Autoimmune Liver Diseases, European Reference Network on Hepatological Diseases (ERN RARE-LIVER), General University Hospital of Larissa, Larissa, Greece., Galli A; Gastroenterologia Clinica, Azienda Ospedaliero-Universitaria Careggi, Florence (Firenze), Italy., Rabinovitz M; Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Heo J; Department of Internal Medicine, College of Medicine, Pusan National University and Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea., Nevens F; Hepatology and Liver Transplantation, University Hospitals KU Leuven, Leuven, Belgium.; Center of European Reference Network (ERN) RARE-LIVER, Leuven, Belgium., Levy C; Division of Digestive Health and Liver Diseases, Miller School of Medicine, University of Miami, Miami, Florida, USA.; Schiff Center for Liver Diseases, Miller School of Medicine, University of Miami, Miami, Florida, USA., Zhou Y; Gilead Sciences, Inc., Foster City, California, USA., Carroll S; Gilead Sciences, Inc., Foster City, California, USA., Crittenden DB; Gilead Sciences, Inc., Foster City, California, USA. |
| Source: | Hepatology communications [Hepatol Commun] 2026 Apr 13; Vol. 10 (5). Date of Electronic Publication: 2026 Apr 13 (Print Publication: 2026). |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III |
| Journal Info: | Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 101695860 Publication Model: eCollection Cited Medium: Internet ISSN: 2471-254X (Electronic) Linking ISSN: 2471254X NLM ISO Abbreviation: Hepatol Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41974026 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Seladelpar in patients with primary biliary cholangitis and compensated cirrhosis: Efficacy and safety from RESPONSE and ASSURE studies. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Gordon+SC%22">Gordon SC</searchLink>; Division of Hepatology, Henry Ford Health, Wayne State University School of Medicine, Detroit, Michigan, USA.; College of Medicine, Michigan State University, East Lansing, Michigan, USA.<br /><searchLink fieldCode="AU" term="%22Villamil+A%22">Villamil A</searchLink>; The Liver Autoimmunity Unit, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.<br /><searchLink fieldCode="AU" term="%22Jacobson+IM%22">Jacobson IM</searchLink>; NYU Grossman School of Medicine, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Lawitz+EJ%22">Lawitz EJ</searchLink>; Texas Liver Institute, University of Texas Health San Antonio, San Antonio, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Younes+Z%22">Younes Z</searchLink>; Gastro One, Germantown, Tennessee, USA.<br /><searchLink fieldCode="AU" term="%22Silveira+MG%22">Silveira MG</searchLink>; Department of Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Bowlus+CL%22">Bowlus CL</searchLink>; Division of Gastroenterology and Hepatology, University of California, Davis School of Medicine, Sacramento, California, USA.<br /><searchLink fieldCode="AU" term="%22Drenth+JPH%22">Drenth JPH</searchLink>; Department of Gastroenterology and Hepatology, Amsterdam UMC, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Vierling+JM%22">Vierling JM</searchLink>; Section of Gastroenterology and Hepatology and Division of Abdominal Transplantation, Baylor College of Medicine, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Morgera+U%22">Morgera U</searchLink>; Internal Medicine, Outpatient Clinic, Charité, Universitätsmedizin Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Vasura+A%22">Vasura A</searchLink>; Department of Internal Medicine and Cardiology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Dalekos+G%22">Dalekos G</searchLink>; Department of Medicine and Research Laboratory of Internal Medicine, National Expertise Center of Greece in Autoimmune Liver Diseases, European Reference Network on Hepatological Diseases (ERN RARE-LIVER), General University Hospital of Larissa, Larissa, Greece.<br /><searchLink fieldCode="AU" term="%22Galli+A%22">Galli A</searchLink>; Gastroenterologia Clinica, Azienda Ospedaliero-Universitaria Careggi, Florence (Firenze), Italy.<br /><searchLink fieldCode="AU" term="%22Rabinovitz+M%22">Rabinovitz M</searchLink>; Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Heo+J%22">Heo J</searchLink>; Department of Internal Medicine, College of Medicine, Pusan National University and Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Nevens+F%22">Nevens F</searchLink>; Hepatology and Liver Transplantation, University Hospitals KU Leuven, Leuven, Belgium.; Center of European Reference Network (ERN) RARE-LIVER, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Levy+C%22">Levy C</searchLink>; Division of Digestive Health and Liver Diseases, Miller School of Medicine, University of Miami, Miami, Florida, USA.; Schiff Center for Liver Diseases, Miller School of Medicine, University of Miami, Miami, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Zhou+Y%22">Zhou Y</searchLink>; Gilead Sciences, Inc., Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Carroll+S%22">Carroll S</searchLink>; Gilead Sciences, Inc., Foster City, California, USA.<br /><searchLink fieldCode="AU" term="%22Crittenden+DB%22">Crittenden DB</searchLink>; Gilead Sciences, Inc., Foster City, California, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101695860%22">Hepatology communications</searchLink> [Hepatol Commun] 2026 Apr 13; Vol. 10 (5). <i>Date of Electronic Publication: </i>2026 Apr 13 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wolters+Kluwer+Health%2C+Inc%22">Wolters Kluwer Health, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101695860 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2471-254X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222471254X%22">2471254X </searchLink><i>NLM ISO Abbreviation: </i>Hepatol Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41974026 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1097/HC9.0000000000000918 Languages: – Code: eng Text: English Titles: – TitleFull: Seladelpar in patients with primary biliary cholangitis and compensated cirrhosis: Efficacy and safety from RESPONSE and ASSURE studies. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gordon SC – PersonEntity: Name: NameFull: Villamil A – PersonEntity: Name: NameFull: Jacobson IM – PersonEntity: Name: NameFull: Lawitz EJ – PersonEntity: Name: NameFull: Younes Z – PersonEntity: Name: NameFull: Silveira MG – PersonEntity: Name: NameFull: Bowlus CL – PersonEntity: Name: NameFull: Drenth JPH – PersonEntity: Name: NameFull: Vierling JM – PersonEntity: Name: NameFull: Morgera U – PersonEntity: Name: NameFull: Vasura A – PersonEntity: Name: NameFull: Dalekos G – PersonEntity: Name: NameFull: Galli A – PersonEntity: Name: NameFull: Rabinovitz M – PersonEntity: Name: NameFull: Heo J – PersonEntity: Name: NameFull: Nevens F – PersonEntity: Name: NameFull: Levy C – PersonEntity: Name: NameFull: Zhou Y – PersonEntity: Name: NameFull: Carroll S – PersonEntity: Name: NameFull: Crittenden DB IsPartOfRelationships: – BibEntity: Dates: – D: 13 M: 04 Text: 2026 Apr 13 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2471-254X Numbering: – Type: volume Value: 10 – Type: issue Value: 5 Titles: – TitleFull: Hepatology communications Type: main |
| ResultId | 1 |